Inventor of Sofosbuvir Discusses Limited Patient Access to Drug

Inventor of Sofosbuvir Discusses Limited Patient Access to Drug
Published on Jun 9, 2015
Michael Sofia, PhD, the inventor of the groundbreaking hepatitis C drug sofosbuvir, discusses the difficulties patients have had in accessing the revolutionary treatment.

Related
Reducing the cost of new hepatitis C drugs 
An index of articles pointing the reader to the current controversy over the high price of Sovaldi, Harvoni (ledipasvir/sofosbuvir) and AbbVie Viekira Pak.